HOME >> BIOLOGY >> NEWS
BioMed Central applauds Wellcome's leadership on Open Access

Publisher BioMed Central today congratulated the Wellcome Trust on its move to require researchers receiving Wellcome funding to deposit copies of resulting research articles in an Open Access archive. The Trust announced its Open Access policy on 19 May.

"For too long, funders have stood by as the results of scientific and medical research have been handed over to traditional publishers, who have then put those research articles behind subscription barriers," said Matthew Cockerill, Director of Operations at BioMed Central. "Subscription-only access to research does not meet the needs of researchers, funders, or the general public, all of whom benefit from the widest possible access to research findings, which is what Open Access delivers."

"Following on from the National Institutes of Health's similar initiative in the USA, Wellcome's move shows that the funders who spend hundreds of millions of pounds to carry out the research in the first place are no longer prepared to see their research results remain inaccessible."

The Wellcome Trust is the UK's biggest non-governmental funder of biomedical research with an annual spend of 400 million. The recipients of Wellcome's funding produce almost 3500 scientific articles each year. With such a major funding body backing Open Access, it is now expected that other funding bodies around the world will follow suit.

Wellcome's policy specifies that articles must be made freely available within, at most, six months of initial publication, but BioMed Central called on researchers to go further and to make their research accessible immediately on publication, by choosing an Open Access journal."

"Six months is a long time in science with the rapid pace of research, quick access to the latest results is vital. So, the best way for researchers to meet the spirit of the Wellcome policy is to publish in fully Open Access journals, such as those published by BioMed Central."

Publishi
'"/>

Contact: Grace Baynes
press@biomedcentral.com
44-20-7631-9988
BioMed Central
25-May-2005


Page: 1 2

Related biology news :

1. BioMed Central announces new interdisciplinary Biofuels Journal
2. BioMed Central announces winners of first open access research awards
3. BioMed Central launches BMC Systems Biology, a new open access journal
4. Impressive new Impact Factors for BioMed Centrals open-access journals
5. BioMed Central launches Biology Direct
6. BioMed Central welcomes the new National Institutes of Health public access policy
7. BioMed Central announces publishing partnership with The Scientist magazine
8. Woods Hole Research Center scientists study impacts of industrial logging in Central Africa
9. Central and peripheral signals set the circadian liver clock
10. Announcing the launch of Open Access Central
11. EMBL-EBI and collaborators win bid to run UK PubMed Central

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/1/2016)... NEW YORK , Feb. 1, 2016  Today, ... Heart Association (AHA) announced plans to develop a first ... cognitive computing power of IBM Watson. In the first ... disease, AHA, IBM (NYSE: IBM ), and Welltok ... metrics and health assessments with cognitive analytics, delivered on ...
(Date:1/25/2016)... , Jan. 25, 2016   Unisys Corporation (NYSE: ... at John F. Kennedy (JFK) International Airport, New York ... (CBP) identify imposters attempting to enter the United ... belong to them. pilot testing of the system ... at three terminals at JFK during January 2016. --> ...
(Date:1/21/2016)... 21, 2016 --> ... market research report "Emotion Detection and Recognition Market by Technology ... (Facial Expression, Voice Recognition and Others), Services, Application ... to 2020", published by MarketsandMarkets, the global Emotion ... USD 22.65 Billion by 2020, at a CAGR ...
Breaking Biology News(10 mins):
(Date:2/8/2016)... FLINT, Mich. , Feb. 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that ... as a specialty pharmacy resource–user-centric, story-driven, knowledge-based and mobile-friendly. ... ... ... "The ...
(Date:2/5/2016)...  In the pharmaceutical industry the medical affairs function ... activities including the identification and engagement of key thought ... high in the oncology therapeutic area where most treating ... Role of Medical Affairs in Oncology Launch Excellence ." ... find better ways to utilize medical affairs to develop ...
(Date:2/4/2016)... -- - New FDA action date of July ... date of July 22, 2016   --> ... 2016   - Lifitegrast has the potential ... the treatment of signs and symptoms of dry eye disease in ... be the only product approved in the U.S. in the past decade indicated for the ...
(Date:2/4/2016)... N.J. , Feb. 4, 2016  CytoSorbents ... immunotherapy leader commercializing its flagship CytoSorb® blood filter ... surgery patients around the world, announced that CEO ... present at the Source Capital Group,s 2016 Disruptive ... update on the company.  Conference ...
Breaking Biology Technology:
Cached News: